Atrial fibrillation (AF) after radiotherapy (RT) in patients with breast cancer (BC) is a relatively new and understudied topic.
AF can increase the risk of stroke and other serious cardiovascular complications, compromising patients' quality of life and survival.
Screening of AF, both asymptomatic and symptomatic forms, is therefore essential for optimal management.
